4
Changes in Ownership
RedHill Biopharma Ltd. Filed Acc 0001178913-26-003473
Chief Operating Officer sold 14,130,000 shares at $0.00 ($1,413)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Raday Gilead Chief Operating Officer | 2026-07-10 | Sale | −14,130,000 | $0.00 | $1,413 | 218,780,000 | D |
| Derivatives | |||||||
| Raday Gilead Chief Operating Officer | 2026-07-10 | Option exercise · American Depositary Shares | +28,150,000 | 104,130,000 | D | ||
| Open-market sales · 14,130,000 sh · avg $0.00 · $1,413 | |||||||
Loading xslF345X06/ownership.xml…